Acute lymphoblastic leukemias; haematologic comparison between two treatment protocols
Professional Medical Journal-Quarterly [The]. 2002; 9 (4): 367-374
em Inglês
| IMEMR
| ID: emr-60660
ABSTRACT
The present study conducted by the authors showed that in 1st group out of 21 cases, 3 left and remaining total 18 patients of ALL who received conventional treatment 16 [92%] showed complete remission and 2 died showed non-remission. In this group 10 [62%] showed complete remission after 2 months while 6 [38%] showed remission after 3 months. Similarly in 2nd group out of 21 cases, 4 left and in remaining 17 patients who received conventional therapy without L-asnase 16 [94%] showed complete remission and 1 [8%] died. The 16 patients who were in remission and received conventional treatment along with L-asnase enzyme showed complete remission in 14 [87%] cases after 2 months of treatment and 2 [13%] after 3 months of duration. The estimation of various parameters were continued till 6 months which showed maintenance of remission in 15[94%] patients in 1st group and all [100%] patients in 2nd group. This showed that the recommended chemotherapy without any L-asnase is less effective as induction of remission therapy while the addition of L-asnase enzyme in that treatment resulted in intensification of results which are maintained for longer time
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Bioquímica
/
Indução de Remissão
/
Protocolos Clínicos
/
Resultado do Tratamento
/
Leucemia-Linfoma Linfoblástico de Células Precursoras
/
Testes Hematológicos
Tipo de estudo:
Relato de Casos
/
Guia de Prática Clínica
Limite:
Humanos
Idioma:
Inglês
Revista:
Professional Med. J.-Q
Ano de publicação:
2002
Similares
MEDLINE
...
LILACS
LIS